(Q34402839)

1 August 2017

1 reference

title

Trimethoprim-sulfamethoxazole as a viable treatment option for infections caused by methicillin-resistant Staphylococcus aureus (English)

1 reference

methicillin-resistant Staphylococcus aureus

1 August 2017

main subject

0 references

Staphylococcus aureus

1 reference

Shellee A Grim

1

1 reference

1 August 2017

Robert P Rapp

series ordinal

2

1 reference

1 August 2017

Craig A Martin

series ordinal

3

1 reference

1 August 2017

Martin E Evans

series ordinal

4

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 February 2005

1 reference

1 August 2017

1 reference

1 August 2017

volume

25

1 reference

1 August 2017

issue

2

1 reference

1 August 2017

page(s)

253-264

1 reference

Staphylococcus aureus: a well-armed pathogen

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.2.253.56956

Staphylococcus aureus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.2.253.56956

Nosocomial bloodstream infections in United States hospitals: a three-year analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.2.253.56956

Severe Staphylococcus aureus Infections Caused by Clonally Related Community-Acquired Methicillin-Susceptible and Methicillin-Resistant Isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.2.253.56956

Outcome and attributable mortality in critically Ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.2.253.56956

The economic impact of Staphylococcus aureus infection in New York City hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.2.253.56956

Is Methicillin-Resistant Staphylococcus aureus More Virulent than Methicillin-Susceptible S. aureus? A Comparative Cohort Study of British Patients with Nosocomial Infection and Bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.2.253.56956

Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.2.253.56956

Cost effect of managing methicillin-resistant Staphylococcus aureus in a long-term care facility

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.2.253.56956

Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.2.253.56956

Linezolid resistance since 2001: SENTRY Antimicrobial Surveillance Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.2.253.56956

Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.2.253.56956

Safety and tolerability of quinupristin/dalfopristin: administration guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.2.253.56956

Linezolid versus vancomycin for methicillin-resistant Staphylococcus aureus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.2.253.56956

Opportunistic infections in patients with and patients without Acquired Immunodeficiency Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.2.253.56956

The prevalence and mechanisms of vancomycin resistance in Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.2.253.56956

Community-acquired and clindamycin-susceptible methicillin-resistant Staphylococcus aureus in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.2.253.56956

Emergence of trimethoprim-sulfamethoxazole resistance in the AIDS era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.2.253.56956

Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.2.253.56956

The rapid emergence of fluoroquinolone-methicillin-resistant Staphylococcus aureus infections in a community hospital. An in vitro look at alternative antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.2.253.56956

Management and epidemiologic analyses of an outbreak due to methicillin-resistant Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.2.253.56956

Community-acquired methicillin-resistant Staphylococcus aureus infections in south Texas children

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.2.253.56956

Colonization of HIV-infected outpatients in Taiwan with methicillin-resistant and methicillin-susceptible Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.2.253.56956

Clonal and antibiotic resistance profiles of methicillin-resistant Staphylococcus aureus (MRSA) from a Portuguese hospital over time

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.2.253.56956

Methicillin-resistance among Turkish isolates of Staphylococcus aureus strains from nosocomial and community infections and their resistance patterns using various antimicrobial agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.2.253.56956

Effect of trimethoprim-sulfamethoxazole prophylaxis in AIDS patients on the formation of the small colony variant phenotype of Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.2.253.56956

Attempts to eradicate methicillin-resistant Staphylococcus aureus colonization with the use of trimethoprim-sulfamethoxazole, rifampin, and bacitracin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.2.253.56956

Trimethoprim-sulfamethoxazole treatment of multiantibiotic-resistant staphylococcal endocarditis and meningitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.2.253.56956

In-vitro and in-vivo studies of trimethoprim-sulphamethoxazole against multiple resistant Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.2.253.56956

Trimethoprim-sulfamethoxazole revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.2.253.56956

Efficacy of linezolid in treatment of experimental endocarditis caused by methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.2.253.56956

Successful use of oral linezolid as a single active agent in endocarditis unresponsive to conventional antibiotic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.2.253.56956

Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.2.253.56956

Successful treatment of methicillin-resistant Staphylococcus aureus endocarditis with linezolid

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.2.253.56956

Occurrence of MRSA endocarditis during linezolid treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.2.253.56956

Endocarditis caused by methicillin-resistant Staphylococcus aureus: treatment failure with linezolid

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.2.253.56956

Efficacy of linezolid alone or in combination with vancomycin for treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.2.253.56956

“Celbenin” - resistant Staphylococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.2.253.56956

Spread of a Methicillin-Resistant and Multiresistant Epidemic Clone of Staphylococcus aureus in Argentina

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.2.253.56956

10.1592/PHCO.25.2.253.56956

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference